(Reuters) - Moderna Inc said on Monday it is proposing filling vials with additional doses of the COVID-19 vaccine to ease a crunch in manufacturing as the company approaches the manufacturing of ...

Moderna’s updated booster for adults comes in vials that have a dark blue cap ... Administration errors are also a known issue. After Covid vaccines were authorized for children, there were ...

Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its Phase III trials, which test how well a new treatment works compared to ...

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety ...

Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the FDA’s attitude toward mRNA and COVID-19 vaccines that have investors ...

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has ...

The change in recommendations for pregnant women has particularly concerned many doctors. The American College of ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.